BNF for Children 2014-2015 (British National Formulary)
BNF for Children aims to
provide prescribers, pharma-cists, and other healthcare professionals with
sound up-to-date information on the use of medicines for treating children.
A joint publication of the
British Medical Association, the Royal Pharmaceutical Society, the Royal
College of Paediatrics and Child Health, and the Neonatal and Paediatric
Pharmacists Group, BNF for Children (‘BNFC’) is published under the authority
of a Paediatric Formulary Committee which comprises representatives of these
bodies, the Department of Health for England, and the Medicines and Healthcare
products Regulatory Agency.
Many areas of paediatric practice
have suffered from inadequate information on effective medicines. BNFC
addresses this significant knowledge gap by providing practical information on
the use of medicines in children of all ages from birth to adolescence.
Information in BNFC has been validated against emerging evidence, best-practice
guidelines, and crucially, advice from a network of clinical experts.
Drawing information from
manufacturers’ literature where appropriate, BNFC also includes a great deal of
advice that goes beyond marketing authorisations (pro-duct licences). This is
necessary because licensed indi-cations frequently do not cover the clinical
needs of children; in some cases, products for use in children need to be
specially manufactured or imported. Careful consideration has been given to
establishing the clinical need for unlicensed interventions with respect to the
evidence and experience of their safety and efficacy; local paediatric
formularies, clinical literature and national information resources have been
invaluable in this process.
BNFC has been designed for
rapid reference and the information presented has been carefully selected to
aid decisions on prescribing, dispensing and administration of medicines. Less
detail is given on areas such as malignant disease and the very specialist use
of medi-cines generally undertaken in tertiary centres. BNFC should be
interpreted in the light of professional knowl-edge and it should be
supplemented as necessary by specialised publications. Information is also
available from Medicines Information Services (see inside front cover).
It is important to use the
most recent BNFC informa-tion for making clinical decisions., and the NHS
Evi-dence portal. The more important changes for this edition are listed on p.
xvii; changes listed online are cumulative (from one print edition to the
next), and can be printed off each month to show the main changes since the
last print edition as an aide memoire for those using print copies.
For More Book:
BNF 80 (British National Formulary September 2020 - March 2021)
BNF 79 (British National Formulary March 2020 - September 2020)
BNF 78 (British National Formulary September 2019 - March 2020)
BNF 76 (British National Formulary September 2018 - March 2019)
BNF 74 (British National Formulary September 2017-March 2018)
BNF 73 (British National Formulary March 2017-September 2017)
BNF 71 (British National Formulary March-September 2016)
BNF 68 (British National Formulary September 2014- March 2015)
BNF 66 (British National Formulary September 2013- March 2014)
No comments:
Post a Comment